• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Research

The US Department of Health and Human Services building is shown in Washington DC 21 July 2007
Biotech

HHS division refers Harvard for potential debarment

If Harvard undergoes debarment, the university would be blocked from business relations with any federal agency for a specified time frame.
Eric Sagonowsky Sep 29, 2025 4:59pm
viking ship long boat chase race water sunset

BioLineRx forges joint cancer venture with Norwegian biotech

Sep 29, 2025 11:22am
Anthony Letai
Sponsored

Dana-Farber oncologist Anthony Letai tapped to direct NCI

Sep 30, 2025 5:50am
Fish oil pills sitting in a fish-shaped dish

Fatty acid eye injections restore vision in old mice

Sep 26, 2025 2:10pm
denovirus transmission replication treatments 3D scientific illustration

Biogen discontinues all AAV gene therapy work

Sep 26, 2025 11:04am
DNA genome CRISPR gene editing

ARPA-H unveils programs to develop custom gene editing therapies

Sep 26, 2025 10:41am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings